Intravenous Tranexamic Acid for Subdural and Epidural Intracranial Hemorrhage: Randomized, Double-Blind, Placebo-Controlled Trial

• Published in: Reviews on recent clinical trials Vol. 14; no. 4; p. 286
• Main Authors: Ebrahimi, Pouya, Mozafari, Javad, Ilkhchi, Reza Bahrami, Hanafi, Mohammad Ghasem, Mousavinejad, Maryam
• Format: Journal Article
• Language: English
• Published: United Arab Emirates 01.01.2019
• Subjects: Adult; Antifibrinolytic Agents - administration & dosage; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Hematoma, Epidural, Cranial - diagnosis; Hematoma, Epidural, Cranial - drug therapy; Hematoma, Subdural - diagnosis; Hematoma, Subdural - drug therapy; Humans; Infusions, Intravenous; Male; Retrospective Studies; Tomography, X-Ray Computed; Tranexamic Acid - administration & dosage; Treatment Outcome; Young Adult; clinical trial; trauma; intraparenchymal hemorrhage; Emergency medicine; hemoglobin (Hb); tranexamic acid
• ISSN: 1876-1038
• DOI: 10.2174/1574887114666190620112829

Recovery of patients with traumatic brain injury largely depends on the reduction in secondary brain damage. The present study aims at investigating the effect of Tranexamic Acid (TXA) administration within the first hours of brain trauma in the emergency department (ED). This randomized, double-blind, placebo-controlled clinical trial was carried out in patients with subdural and epidural hemorrhage. Patients with any type of bleeding were assigned into two groups of TXA and 0.9% normal saline as placebo. The rate of intracranial hemorrhage after surgery was assessed by CT-scan and amount of hemoglobin (Hb) was measured immediately before surgery and after 6 hours of surgery. A total of 80 participants were randomly assigned into four groups of 20 people. There was a significant difference in the mean of intraoperative bleeding during surgery in patients receiving TXA and placebo in both SDH (Subdural hematoma) and EDH (Epidural Hemorrhage) groups (P= 0.012). The Hb drop amount had no significant difference with placebo (P< 0.0001). No complications were observed in any of the intervention and control groups during the study as well. The use of TXA may reduce bleeding, however, based on the results of this study, such effect was not statistically significant in controlling the epidural and subdural hemorrhage, but clinical trials with a higher sample size are suggested for further investigation in this regard.